IHC staining confirms that 5T4 is overexpressed in a range of solid tumors but not in normal tissues, indicating that ALG.APV-527 may primarily localize to the tumor improving potential for a achieving concentrations that demonstrate efficacy in a solid tumor setting. Here, TPBG is linked to neoplasm.